Lack of Evidence for a Role of ACE-2 Polymorphisms as a Bedside Clinical Prognostic Marker of COVID-19

Lack of Evidence for a Role of ACE-2 Polymorphisms as a Bedside Clinical Prognostic Marker of COVID-19

The novel SARS-CoV-2 coronavirus causes a severe respiratory syndrome referred to as coronavirus disease (COVID-19). The angiotensin-converting enzyme 2 (ACE-2) plays an important role as a cellular receptor for SARS-CoV-2 and is largely expressed in lungs, kidneys, heart and the gastrointestinal tr...

Full description

Bibliographic Details
Main Authors: Josè R. Fiore, Mariantonietta Di Stefano, Andrew Oler, Yu Zhang, Jingwen Gu, Clifton L. Dalgard, Giuseppina Faleo, Brian Epling, Luigi Notarangelo, Andrea Lisco, Teresa A. Santantonio
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Viruses
Subjects:
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
angiotensin-converting enzyme 2 (ACE-2)
respiratory distress syndrome (ARDS)
single nucleotide polymorphism (SNP)
Online Access:https://www.mdpi.com/1999-4915/15/7/1448

Internet

https://www.mdpi.com/1999-4915/15/7/1448

Similar Items